Grizzly Bulls
Financial research concept

Contract Research Backlog Inclusion Policy

defines when expected clinical-research work is allowed into backlog and when cancellations, funding uncertainty, timing, or scope changes remove or defer it.

By Lee BaileyPublished Sep 28, 2026
Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date
Sep 28, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context
10 connected conceptsPart of the reviewed Contract Research Organization Economics; issuer definitions remain distinct where disclosed.
Company examples
3 reviewed companiesRelationships reflect supported examples, not a normalized cross-company KPI ranking.
  1. A signed opportunity can still fail the backlog test
  2. Cancellation rules can rewrite history
  3. Part of the Contract Research Organization Economics
  4. See It in Company Research
  5. Continue Research

A contract research backlog inclusion policy is the issuer's rule set for deciding which expected clinical-research revenue is credible enough to enter backlog and when it must be removed or revised.

Medpace recognizes new business awards after a signed contract or written pre-contract confirmation, but it can withhold amounts when funding, regulatory hurdles, or study timing remain too uncertain. It also excludes study amounts extending beyond three years from the measurement date. IQVIA takes a narrower contractual starting point in its backlog definition, describing future revenue from work not yet completed under signed contracts.

A signed opportunity can still fail the backlog test

The policy is meant to filter a commercial pipeline into a narrower operating measure. A sponsor may have agreed in principle on budget and scope while the CRO still judges future revenue too uncertain to include.

That makes the policy central to interpreting net new business awards and contract research backlog. Two companies can have similar commercial momentum but publish different backlog balances because their recognition windows and risk filters differ.

Cancellation rules can rewrite history

ICON changed its cancellations methodology effective October 1, 2025 so quarterly cancellation amounts include customer notifications plus studies that had become inactive or were identified as at risk. The change cut reported backlog by $3.9B at implementation, even though ICON said its treatment of awards entering backlog was unchanged.

This is why a backlog-policy change should be treated like a measurement-basis change, not merely a footnote. Investors comparing periods should identify whether the reported series has been recast and whether business cancellations are being recognized earlier.

Primary sources: Medpace 2025 Form 10-K, IQVIA 2025 Form 10-K, and ICON fourth-quarter 2025 results.

Part of the Contract Research Organization Economics

Connect clinical-research awards, cancellations, book-to-bill, backlog policy and conversion, near-term revenue visibility, and reimbursed pass-through activity across contract research organizations.

Browse the full operating model in Company Analysis →
Where this concept fits
  • Backlog quality, timing, and conversionCurrent relationship
    Backlog captures expected contracted work, inclusion policy defines which work qualifies, RPO preserves a separate accounting boundary, next-twelve-month backlog shows near-term timing, and backlog conversion indicates how quickly the booked work becomes revenue.
    CRO BacklogCRO Backlog ConversionCRO Backlog PolicyCurrent conceptCRO Backlog vs. RPOCRO NTM Backlog
  • Awards, cancellations, and demand coverage
    Net new awards or bookings incorporate cancellations, while book-to-bill compares that net commercial inflow with current revenue. Together they show whether newly won work is replenishing the revenue base without treating gross wins as guaranteed future revenue.
    CRO Book-to-BillCRO CancellationsCRO Net New Awards
  • Pass-through costs and underlying service growth
    Reimbursed expenses can materially change reported clinical-research revenue and costs without adding equivalent service economics, so revenue excluding reimbursed expenses helps isolate the underlying service-growth read.
    CRO Reimbursed ExpensesCRO Revenue ex Reimbursements

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare backlog recognition rules

Compare when signed or pre-contract clinical work enters backlog and how funding, regulatory, timing, cancellation, and duration filters differ.

Continue research

Explore more topics in the Financial Research Encyclopedia.